🏢 官网IRMEDDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 04:05:00(美东 10-14 16:05)·⟳ 抓取 04:06:26回填·⚡ 决策 10-15 04:07:46·12.8 天前
Medifast(MED)宣布将于10月26日盘前公布2026年三季报，仅为业绩日期/电话会通知
这是一份例行的财报日期/电话会通知(pre-announcement scheduling)，没有任何财务结果、指引、经营数据或超预期信息，无法据此形成做多或做空方向；真正的催化在10月26日财报本身。
📄 原文MED↗ 原文
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026
BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the metabolic health and wellness company known for its science-back…
不做 Medifast, Inc.（MED.US）
纯财报日期/电话会通知，无业绩、指引或经营数据增量，方向与edge均不成立；真正催化在2026-10-26盘前实际财报，届时再研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Medifast仅宣布Q3财报将于10月26日盘前发布，无任何业绩或指引增量，属中性程序性日历事件，不构成可交易催化，AVOID。
🔎 新鲜度:最早出现 2026-10-14 · 扩散 low · price-in 风险 low ↗
关键理由
- 无方向性事实支撑：稿件仅确定财报披露时间与电话会安排，不含任何改变盈利预期的新增信息。
主要风险
- 真正波动来自10月26日实际财报与指引，当前提前下注等于无信息暴露；若需参与应等待财报数据发布后再研判。
先例如何影响了这次决策
对本次决策的影响:确认不应在仅有日期通知时开仓；等待10月26日实际财报后再评估。
方向:无同类价格先例可参照；财报日期通知本身通常不引发方向性重定价，真正催化在实际财报日。
涨幅量级:无可校准幅度，因当前事件不含财务增量。
形态:纯日历通知一般无显著股价反应，不构成见光死或动量信号。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 9 ms
{"result": "search_processed_events:agent query=`medifast med third quarter 2026 earnings date announcement october 26 conference call | medifast q3 2026 financial results release date trilivy`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前
原文全文
展开原文 · 2,479 字
BALTIMORE--(BUSINESS WIRE)--
Medifast
(NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, will announce financial results for the quarter ended September 30, 2026 on Monday, October 26, 2026, before market open. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
The conference call is scheduled to begin at 8:30 a.m. ET on October 26, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at
www.MedifastInc.com
or directly at
https://viavid.webcasts.com/starthere.jsp?ei=1777297&tp_key=e45ccefd73
and will be archived online and available through January 26, 2027. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 12:30 p.m. ET, October 26, 2026, through November 2, 2026. Participants can dial (412) 317-6671 and enter access code 13762848 to hear the playback.
About Medifast®:
Medifast
(NYSE: MED) is the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy. Designed to help address the challenges of metabolic dysfunction, the company’s holistic approach integrates science-backed plans and products, personal 1:1 coaching, a supportive community, and behavioral science support to develop healthy habits.
Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization®, a breakthrough science that targets metabolic dysfunction through a comprehensive system focused on fat loss, lean mass preservation, and long-term health. Trilivy’s comprehensive three-part metabolic health system is designed to help people reset their metabolism, refine their health, and renew their lives. By integrating science, coaching, and healthy habits into a single approach, Trilivy helps people look, feel, and live better.
Backed by more than 45 years of clinical heritage, Medifast continues to advance its mission of lifelong transformation through metabolic science and human connection
TM
. For more information, visit
Trilivyhealth.com
and
Medifastinc.com
.
MED-F
Investor Contact:
Medifast, Inc.
Matt Daryman
InvestorRelations@medifastinc.com
1-800-763-9953
Source: Medifast
Medifast
(NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, will announce financial results for the quarter ended September 30, 2026 on Monday, October 26, 2026, before market open. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
The conference call is scheduled to begin at 8:30 a.m. ET on October 26, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at
www.MedifastInc.com
or directly at
https://viavid.webcasts.com/starthere.jsp?ei=1777297&tp_key=e45ccefd73
and will be archived online and available through January 26, 2027. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 12:30 p.m. ET, October 26, 2026, through November 2, 2026. Participants can dial (412) 317-6671 and enter access code 13762848 to hear the playback.
About Medifast®:
Medifast
(NYSE: MED) is the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy. Designed to help address the challenges of metabolic dysfunction, the company’s holistic approach integrates science-backed plans and products, personal 1:1 coaching, a supportive community, and behavioral science support to develop healthy habits.
Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization®, a breakthrough science that targets metabolic dysfunction through a comprehensive system focused on fat loss, lean mass preservation, and long-term health. Trilivy’s comprehensive three-part metabolic health system is designed to help people reset their metabolism, refine their health, and renew their lives. By integrating science, coaching, and healthy habits into a single approach, Trilivy helps people look, feel, and live better.
Backed by more than 45 years of clinical heritage, Medifast continues to advance its mission of lifelong transformation through metabolic science and human connection
TM
. For more information, visit
Trilivyhealth.com
and
Medifastinc.com
.
MED-F
Investor Contact:
Medifast, Inc.
Matt Daryman
InvestorRelations@medifastinc.com
1-800-763-9953
Source: Medifast
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
741d6a9356· 2026-10-15 04:07 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前